Morabito Christopher
Insider CIK 1859284 · ATXS Chief Medical Officer · FULC Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 80,000 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 262,500 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2025-03-21 | 2025-03-25 | 262,500 | — | $0 | 262,500 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | M Exercise deriv | 2024-04-01 | 2024-04-03 | 10,000 | — | $0 | 80,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 10,000 | $13.59 | $135.9K | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | M Exercise | 2024-04-01 | 2024-04-03 | 10,000 | $3.87 | $38.7K | 10,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2024-02-08 | 2024-02-12 | 175,000 | — | $0 | 175,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | M Exercise deriv | 2024-01-29 | 2024-01-30 | 9,200 | — | $0 | 90,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | M Exercise | 2024-01-29 | 2024-01-30 | 9,200 | $3.87 | $35.6K | 9,200 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | S Sale | 2024-01-29 | 2024-01-30 | 9,200 | $11.15 | $102.6K | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | M Exercise deriv | 2024-01-26 | 2024-01-30 | 800 | — | $0 | 99,200 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | S Sale | 2024-01-26 | 2024-01-30 | 800 | $11.02 | $8.8K | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | M Exercise | 2024-01-26 | 2024-01-30 | 800 | $3.87 | $3.1K | 800 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-08-01 | 2022-08-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2022-01-19 | 2022-01-21 | 59,744 | — | $0 | 59,744 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | P Buy | 2021-06-28 | 2021-06-29 | 1,100 | $9.16 | $10.1K | 1,100 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2021-05-10 | 2021-05-12 | 163,000 | — | $0 | 163,000 | SEC↗ |